Journal of Sickle Cell Disease and Hemoglobinopathies
Title Abbreviation
J Sick Cell Dis Hemoglobinopathies
Electronic ISSN
2330-1473
Readership
Allied Health Professionals, Biomedical Researchers, Clinical Pharmacologists, Clinicians, Hematologists, Pathologists, Pharmacologists, Physicians, Physicians - Medicine, Policy Makers, Public Health Professionals, Researchers, Scientists
Scope
The Journal of Sickle Cell Disease and Hemoglobinopathies (JSCDH), an official publication
of the Foundation for Sickle Cell Disease Research (FSCDR) publishes peer-reviewed
abstracts and articles of interest to clinicians, researchers, public health and health policy experts
in the field of sickle cell disease and hemoglobinopathies. The Journal’s scope is
multidisciplinary, representing all topics related to sickle cell disease and hemoglobinopathies.
Original state-of-the-art reviews, clinical studies, experimental investigations, new therapeutics,
case reports, editorials, articles on the business of sickle cell disease and hemoglobinopathies,
feature articles and letters to the editor are published.
The Journal of Sickle Cell Disease and Hemoglobinopathies was established in 2013 as a
forum for all physicians, scientists, allied healthcare, public health professionals, pharmaceutical
and biotechnology researchers and developers, who are engaged or interested in sickle cell
disease and hemoglobinopathies. The Journal seeks to support sickle cell disease and
hemoglobinopathy specialists of all disciplines, improve patient care, and promote research and
development by publishing peer-reviewed materials related to the field of sickle cell disease and
hemoglobinopathies.
Sponsoring Association(s)
Foundation for Sickle Cell Disease Research (FSCDR)
Publisher Name
Foundation for Sickle Cell Disease Research (FSCDR)
To see more details about Journal of Sickle Cell Disease and Hemoglobinopathies,
Subscribe Now!
Frequency
Author Submission Guidelines